NCT05904301 Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
| NCT ID | NCT05904301 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Santé Arménie French-Armenian Research Center |
| Condition | Behcet Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2023-06-21 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2023-06-21 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Longitudinal prospective multicenter Armenian registry of systemic autoimmune, autoinflammatory diseases with constitution of bio-banking.
Eligibility Criteria
Inclusion Criteria: 1. Patients with a confirmed diagnosis of at least one of following autoimmune systemic diseases: Behcet disease, ANCA -positive vasculitis, Takayasu arteritis, Giant cell arteritis, Systemic sclerosis, Sjogren syndrome, Rheumatoid arthritis, Spondylarthritis (psoriatic, ankylosing, crohn's related), Angioedema hereditary and acquired, Pediatric dermatology, Autoinflammatory diseases (hereditary and acquired), Unexplained infertility, Immune thrombocytopenic purpura/ Autoimmune hemolytic anemia (ITP, AHA), Primary anti-phospholipid syndrome (APS), Celiac disease. 2. Age: major and minor 3. Patients who have been informed and provided with written informed consent to participate Or consent from legal representative Exclusion Criteria: 1. Patients refusing to participate in the registry 2. Non-consent from legal representative 3. Breastfeeding or pregnant patients
Contact & Investigator
Merry Mazmanian, Dr.
STUDY DIRECTOR
Santé Arménie French - Armenian Academic Research Organization FAARO
Frequently Asked Questions
Who can join the NCT05904301 clinical trial?
This trial is open to participants of all sexes, studying Behcet Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05904301 currently recruiting?
Yes, NCT05904301 is actively recruiting participants. Contact the research team at arsene.mekinian@aphp.fr for enrollment information.
Where is the NCT05904301 trial being conducted?
This trial is being conducted at Yerevan, Armenia, Yerevan, Armenia, Yerevan, Armenia, Yerevan, Armenia and 2 additional locations.
Who is sponsoring the NCT05904301 clinical trial?
NCT05904301 is sponsored by Santé Arménie French-Armenian Research Center. The principal investigator is Merry Mazmanian, Dr. at Santé Arménie French - Armenian Academic Research Organization FAARO. The trial plans to enroll 800 participants.